Examining the Clinical Effectiveness of Non-Carbapenem beta-Lactams for the Treatment of Extended-Spectrum beta-Lactamase-Producing Enterobacteriaceae

被引：2
作者：
Gibble, Allison M. [1 ,2 ]
Gross, Alan E. [3 ]
Huang, Angela M. [1 ,2 ]
机构：
[1] Froedtert, Dept Pharm, Milwaukee, WI 53226 USA
[2] Med Coll Wisconsin, Milwaukee, WI 53226 USA
[3] Univ Illinois, Coll Pharm, Dept Pharm Practice, Chicago, IL 60612 USA
来源：
ANTIBIOTICS-BASEL | 2015年 / 4卷 / 04期
关键词：
extended-spectrum beta-lactamases; piperacillin-tazobactam; cefepime; carbapenems;
D O I：
10.3390/antibiotics4040653
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
Treatment options for extended-spectrum -lactamase-producing Enterobacteriaceae are limited. Piperacillin-tazobactam and cefepime represent potential alternative treatment options; however, large prospective studies are lacking. This review evaluates the current literature regarding use of piperacillin-tazobactam and cefepime for the treatment of extended-spectrum -lactamase-producing Enterobacteriaceae. Antimicrobial stewardship programs can play a key role in guiding the best practices for the management of these challenging infections.
引用
收藏
页码：653 / 666
页数：14
相关论文
共 41 条
  • [31] Can We Really Use ß-Lactam/ß-Lactam Inhibitor Combinations for the Treatment of Infections Caused by Extended-Spectrum ß-Lactamase-Producing Bacteria?
    Perez, Federico
    Bonomo, Robert A.
    [J]. CLINICAL INFECTIOUS DISEASES, 2012, 54 (02) : 175 - 177
  • [32] β-Lactam/β-Lactam Inhibitor Combinations for the Treatment of Bacteremia Due to Extended-Spectrum β-Lactamase-Producing Escherichia coli: A Post Hoc Analysis of Prospective Cohorts
    Rodriguez-Bano, Jesus
    Navarro, Maria Dolores
    Retamar, Pilar
    Picon, Encarnacion
    Pascual, Alvaro
    [J]. CLINICAL INFECTIOUS DISEASES, 2012, 54 (02) : 167 - 174
  • [33] Pharmacokinetic-pharmacodynamic rationale for cefepime dosing regimens in intensive care units
    Roos, Juliana F.
    Bulitta, Jurgen
    Lipman, Jeffrey
    Kirkpatrick, Carl M. J.
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2006, 58 (05) : 987 - 993
  • [34] Carbapenem Therapy Is Associated With Improved Survival Compared With Piperacillin-Tazobactam for Patients With Extended-Spectrum β-Lactamase Bacteremia
    Tamma, Pranita D.
    Han, Jennifer H.
    Rock, Clare
    Harris, Anthony D.
    Lautenbach, Ebbing
    Hsu, Alice J.
    Avdic, Edina
    Cosgrove, Sara E.
    [J]. CLINICAL INFECTIOUS DISEASES, 2015, 60 (09) : 1319 - 1325
  • [35] Predictors of mortality in patients with bloodstream infections caused by extended-spectrum-β-lactamase-producing enterobacteriaceae:: Importance of inadequate initial antimicrobial treatment
    Tumbarello, Mario
    Sanguinetti, Maurizio
    Montuori, Eva
    Trecarichi, Enrico M.
    Posteraro, Brunella
    Fiori, Barbara
    Citton, Rita
    D'Inzeo, Tiziana
    Fadda, Giovanni
    Cauda, Roberto
    Spanu, Teresa
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2007, 51 (06) : 1987 - 1994
  • [36] Susceptibility of Extended-Spectrum-β-Lactamase-Producing Enterobacteriaceae According to the New CLSI Breakpoints
    Wang, Peng
    Hu, Fupin
    Xiong, Zizhong
    Ye, Xinyu
    Zhu, Demei
    Wang, Yun F.
    Wang, Minggui
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2011, 49 (09) : 3127 - 3131
  • [37] The inoculum effect of antibiotics against CTX-M-extended-spectrum β-lactamase-producing Escherichia coli
    Wu, Na
    Chen, Bai Yi
    Tian, Su Fei
    Chu, Yun Zhuo
    [J]. ANNALS OF CLINICAL MICROBIOLOGY AND ANTIMICROBIALS, 2014, 13
  • [38] Cefepime versus imipenem-cilastatin for treatment of nosocomial pneumonia in intensive care unit patients: A multicenter, evaluator-blind, prospective, randomized study
    Zanetti, G
    Bally, F
    Greub, G
    Garbino, J
    Kinge, T
    Lew, D
    Romand, JA
    Bille, J
    Aymon, D
    Stratchounski, L
    Krawczyk, L
    Rubinstein, E
    Schaller, MD
    Chiolero, R
    Glauser, MP
    Cometta, A
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2003, 47 (11) : 3442 - 3447
  • [39] Ceftolozane/Tazobactam: A Novel Cephalosporin/β-Lactamase Inhibitor Combination with Activity Against Multidrug-Resistant Gram-Negative Bacilli
    Zhanel, George G.
    Chung, Phillip
    Adam, Heather
    Zelenitsky, Sheryl
    Denisuik, Andrew
    Schweizer, Frank
    Lagace-Wiens, Philippe R. S.
    Rubinstein, Ethan
    Gin, Alfred S.
    Walkty, Andrew
    Hoban, Daryl J.
    Lynch, Joseph P., III
    Karlowsky, James A.
    [J]. DRUGS, 2014, 74 (01) : 31 - 51
  • [40] Ceftazidime-Avibactam: a Novel Cephalosporin/β-lactamase Inhibitor Combination
    Zhanel, George G.
    Lawson, Christopher D.
    Adam, Heather
    Schweizer, Frank
    Zelenitsky, Sheryl
    Lagace-Wiens, Philippe R. S.
    Denisuik, Andrew
    Rubinstein, Ethan
    Gin, Alfred S.
    Hoban, Daryl J.
    Lynch, Joseph P., III
    Karlowsky, James A.
    [J]. DRUGS, 2013, 73 (02) : 159 - 177
12345